Metraipolis › archive › dc_a73d0ba4d136

A Propionate Metabolism-Based Gene Signature Reveals Immunogenomic and Transcriptomic Determinants of Prognosis in Glioblastoma Through Multiomics Integration — Europe PMC PMID:42147808

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42147808
DOI
10.1155/humu/6998123
License (as archived)
solo-consultazione
Archived
2026-11-02T06:24:44.817Z
SHA-256 of the archived text
0f39321b88d917e8415a9dc6f538230953a8ee3fa26b5bb505aafaa148a683c3
Stable URL of this page
https://metraipolis.com/documento/dc_a73d0ba4d136

How to cite

A Propionate Metabolism-Based Gene Signature Reveals Immunogenomic and Transcriptomic Determinants of Prognosis in Glioblastoma Through Multiomics Integration — Europe PMC PMID:42147808 — Europe PMC (en), https://europepmc.org/article/MED/42147808 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a73d0ba4d136 (Metraipolis archive dc_a73d0ba4d136, sha256 0f39321b88d917e8415a9dc6f538230953a8ee3fa26b5bb505aafaa148a683c3)
BibTeX
@misc{dca73d0ba4d136,
  title = {A Propionate Metabolism-Based Gene Signature Reveals Immunogenomic and Transcriptomic Determinants of Prognosis in Glioblastoma Through Multiomics Integration — Europe PMC PMID:42147808},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42147808},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a73d0ba4d136; sha256 0f39321b88d917e8415a9dc6f538230953a8ee3fa26b5bb505aafaa148a683c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147808. Agents can read the archived copy with the MCP tool read_document.